Trevi Therapeutics Inc (TRVI)

07:52 AM

Trevi Therapeutics to present two phase 2a River trial posters at ERS Congress 2025 - MarketScreener

07:52 AM

07:30 AM

Clinical Trial Results: Trevi's Breakthrough Chronic Cough Treatment Data to be Featured at European Congress - Stock Titan

07:30 AM

Sep 17, 2025

Will Trevi Therapeutics Inc outperform its industry peers2025 Trading Recap & Long-Term Capital Growth Strategies - خودرو بانک

Sep 17, 2025

Sep 17, 2025

Trevi Therapeutics (NASDAQ:TRVI) Shares Down 4.6%Here's What Happened - MarketBeat

Sep 17, 2025

Sep 17, 2025

Woodline Partners LP Sells 1,154,785 Shares of Trevi Therapeutics, Inc. $TRVI - MarketBeat

Sep 17, 2025

Sep 17, 2025

Siren L.L.C. Trims Holdings in Trevi Therapeutics, Inc. $TRVI - MarketBeat

Sep 17, 2025

Sep 16, 2025

Trevi Therapeutics (NASDAQ:TRVI) Sees Strong Trading VolumeWhat's Next? - MarketBeat

Sep 16, 2025

Sep 16, 2025

Fred Alger Management LLC Invests $482,000 in Trevi Therapeutics, Inc. $TRVI - MarketBeat

Sep 16, 2025

Sep 16, 2025

Gap Down: What is the PEG ratio of Trevi Therapeutics IncJuly 2025 Movers & AI Powered Trade Plan Recommendations - خودرو بانک

Sep 16, 2025

Sep 16, 2025

Dividend Watch: How much upside does Sintx Technologies Inc. haveMarket Rally & Risk Controlled Stock Pick Alerts - خودرو بانک

Sep 16, 2025

Sep 16, 2025

Revenue Check: How does Trevi Therapeutics Inc compare to its peersJuly 2025 Review & Risk Managed Investment Entry Signals - خودرو بانک

Sep 16, 2025

Sep 16, 2025

Risk Analysis: Will MSAI face regulatory challengesJuly 2025 Spike Watch & AI Driven Price Forecasts - خودرو بانک

Sep 16, 2025

Sep 16, 2025

Aug Volume: How does Trevi Therapeutics Inc compare to its peersQuarterly Trade Summary & Weekly Breakout Opportunity Watchlist - خودرو بانک

Sep 16, 2025

Sep 15, 2025

Aug Wrap: Can Trevi Therapeutics Inc continue delivering strong returnsJuly 2025 Short Interest & Reliable Trade Execution Plans - خودرو بانک

Sep 15, 2025

Sep 15, 2025

Fund Flows: Will AVTX benefit from geopolitical trendsWeekly Trade Analysis & Breakout Confirmation Trade Signals - خودرو بانک

Sep 15, 2025

Sep 15, 2025

Trade Recap: Can Trevi Therapeutics Inc continue delivering strong returnsWeekly Stock Summary & Pattern Based Trade Signal System - خودرو بانک

Sep 15, 2025

Sep 15, 2025

US Market Wrap: Can Trevi Therapeutics Inc. keep up with sector leadersWeekly Trade Review & Daily Volume Surge Signals - خودرو بانک

Sep 15, 2025

Sep 15, 2025

Aug PreEarnings: Will Trevi Therapeutics Inc outperform its industry peersMarket Performance Summary & Entry Point Strategy Guides - خودرو بانک

Sep 15, 2025

Sep 15, 2025

Trevi Therapeutics (NASDAQ:TRVI) Hits New 1-Year HighTime to Buy? - MarketBeat

Sep 15, 2025

Sep 14, 2025

Acorn Capital Advisors LLC Has $13.49 Million Position in Trevi Therapeutics, Inc. $TRVI - MarketBeat

Sep 14, 2025

Sep 14, 2025

Octagon Capital Advisors LP Acquires Shares of 3,322,000 Trevi Therapeutics, Inc. $TRVI - MarketBeat

Sep 14, 2025

Sep 14, 2025

163,738 Shares in Trevi Therapeutics, Inc. $TRVI Purchased by Exome Asset Management LLC - MarketBeat

Sep 14, 2025

Sep 13, 2025

Brokerages Set Trevi Therapeutics, Inc. (NASDAQ:TRVI) PT at $21.75 - MarketBeat

Sep 13, 2025

Sep 13, 2025

Haduvio Opportunity Positions Trevi (TRVI) for Multibagger Gains, Says Morgan Stanley - MSN

Sep 13, 2025

Sep 13, 2025

Trevi Therapeutics (NASDAQ:TRVI) Stock Price Up 8.9%Should You Buy? - MarketBeat

Sep 13, 2025

Sep 12, 2025

Trevi Therapeutics, Inc. $TRVI Shares Sold by Adage Capital Partners GP L.L.C. - MarketBeat

Sep 12, 2025

Sep 12, 2025

Polar Asset Management Partners Inc. Purchases New Shares in Trevi Therapeutics, Inc. $TRVI - MarketBeat

Sep 12, 2025

Sep 12, 2025

Raymond James Financial Inc. Has $3.20 Million Stock Position in Trevi Therapeutics, Inc. $TRVI - MarketBeat

Sep 12, 2025

Sep 12, 2025

Cubist Systematic Strategies LLC Acquires 117,653 Shares of Trevi Therapeutics, Inc. $TRVI - MarketBeat

Sep 12, 2025

Sep 10, 2025

Trevi Therapeutics stock hits 52-week high at $8.80 - Investing.com

Sep 10, 2025

Sep 10, 2025

Trevi Therapeutics stock hits 52-week high at $8.80 By Investing.com - Investing.com Nigeria

Sep 10, 2025

Sep 09, 2025

Trevi Therapeutics at Morgan Stanley Conference: Strategic Focus on Cough Treatments - Investing.com Canada

Sep 09, 2025

Sep 09, 2025

Is Trevi Therapeutics Inc. stock poised for growthWeekly Investment Report & Growth Oriented Trading Recommendations - Newser

Sep 09, 2025

Sep 09, 2025

15 Best Multibagger Stocks to Invest in Right Now - Insider Monkey

Sep 09, 2025

Sep 09, 2025

Retail Trends: Is Trevi Therapeutics Inc. stock technically oversoldBull Run & Consistent Return Investment Signals - Lancaster City Council

Sep 09, 2025

Sep 09, 2025

What the charts say about Trevi Therapeutics Inc. today2025 Retail Activity & Technical Buy Zone Confirmations - Newser

Sep 09, 2025

Sep 09, 2025

What Fibonacci levels say about Trevi Therapeutics Inc. rebound2025 Institutional Moves & Free Weekly Chart Analysis and Trade Guides - Newser

Sep 09, 2025

Sep 09, 2025

Tools to assess Trevi Therapeutics Inc.’s risk profile2025 Volatility Report & Weekly Top Gainers Trade List - Newser

Sep 09, 2025

Sep 09, 2025

Trevi Therapeutics Inc. stock daily chart insightsPortfolio Growth Summary & Daily Growth Stock Tips - Newser

Sep 09, 2025

Sep 08, 2025

Visualizing Trevi Therapeutics Inc. stock with heatmapsMarket Activity Summary & Fast Moving Market Watchlists - Newser

Sep 08, 2025

Sep 08, 2025

Heatmap analysis for Trevi Therapeutics Inc. and competitors2025 Valuation Update & Weekly High Return Opportunities - Newser

Sep 08, 2025

Sep 08, 2025

Panagora Asset Management Inc. Purchases 219,600 Shares of Trevi Therapeutics, Inc. $TRVI - MarketBeat

Sep 08, 2025

Sep 08, 2025

Market reaction to Trevi Therapeutics Inc.’s recent newsJuly 2025 Pullbacks & Short-Term Swing Trade Alerts - Newser

Sep 08, 2025